SCHEMBL19987715

SCHEMBL19987715

CN1CCN(CCOc2cnc3nccc(Oc4ccc(N(C(=O)C5(C(N)=O)CC5)c5ccc(F)cc5)cc4F)c3n2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 18/20 0.36
KDR P35968 3/20 0.35
KIT P10721 3/20 0.35
PDGFRA P16234 3/20 0.35
FLT3 P36888 3/20 0.35
ALK Q9UM73 3/20 0.35
AXL P30530 2/20 0.35
EGFR P00533 2/20 0.35
MST1R Q04912 2/20 0.35
MAPK8 P45983 2/20 0.35
PDGFRB P09619 2/20 0.35
FLT4 P35916 2/20 0.35
PLK4 O00444 1/20 0.35
STK25 O00506 1/20 0.35
CIT O14578 1/20 0.35
AURKA O14965 1/20 0.35
CHUK O15111 1/20 0.35
MUSK O15146 1/20 0.35
EPHB6 O15197 1/20 0.35
MAPK13 O15264 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19987722 0.93 MET (0.42) METKDRKITPDGFRAFLT3
SCHEMBL19987704 0.89 MET (0.46) METKDRKITPDGFRAFLT3
SCHEMBL19987713 0.87 MET (0.42) METKDRKITPDGFRAFLT3
SCHEMBL19987707 0.87 MET (0.43) METKDRKITPDGFRAFLT3
SCHEMBL19987733 0.84 MET (0.46) METKDRKITPDGFRAFLT3
SCHEMBL19987761 0.82 MET (0.38) METKDRKITPDGFRAFLT3
SCHEMBL19987764 0.82 BRAF (0.45) METKDRKITPDGFRAFLT3
SCHEMBL18256893 0.82 MET (0.53) METKDRKITPDGFRAFLT3
SCHEMBL19987748 0.82 MET (0.44) METKDRKITPDGFRAFLT3
SCHEMBL19987706 0.80 MET (0.43) METKDRKITPDGFRAFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-07-14 US claimed
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2018-08-30 US claimed
EP-3299369-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2018-03-28 EP claimed
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-07-14 US disclosed
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2018-08-30 US disclosed
EP-3299369-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2018-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF MET, MERTK, DMPK MET 1/4885KDR 210/4885KIT 85/4885
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof MET, MERTK, DMPK MET 1/4885KDR 210/4885KIT 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.